Hvis en af disse undersøgelser viser abnormalitet, bør det overvejes at kombinere imatinib med profylaktisk brug af systemisk steroid (1- 2 mg/ kg) i en til to uger ved behandlingsstart.
If either is abnormal, follow-up with a cardiology specialist and the prophylactic use of systemic steroids (1– 2 mg/ kg) for one to two weeks concomitantly with imatinib should be considered at the initiation of therapy.